mAb Development

Mar 02, 2009
BioPharm International
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Mar 02, 2009
BioPharm International
Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
Mar 02, 2009
BioPharm International
The future of therapeutic MAbs lies in the development of economically feasible downstream processes.
Jan 01, 2009
BioPharm International
By BioPharm International Editors
A new method for MAb purification.
Dec 01, 2008
BioPharm International
Results from a process developed for a commercial antibody.
Nov 01, 2008
BioPharm International
By BioPharm International Editors
FDA perspectives on specs and effective control strategies.
May 01, 2008
BioPharm International
By BioPharm International Editors
A comparison of primary harvest techniques.
May 01, 2008
BioPharm International
In the context of process validation, the confirmation of a belief must be checked repeatedly, throughout the product lifecycle.
May 01, 2008
BioPharm International
By BioPharm International Editors
Understanding the impact on process performance.
Apr 01, 2008
BioPharm International
The book is a useful, comprehensive, and truly an excellent reference source of biopharmaceutical information.
native1_300x100
lorem ipsum